Opinion

Harvard Business School Professor Amy C. Edmondson talks about achieving psychological safety in the workplace.

From supply-chain and clinical-trial disruptions in Ukraine and Russia, to decisions to halt investment or maintain operations, global implications for industry and pharmaceutical production are immense.

The life sciences industry is at an inflection point, with pressures around pricing, patient access, and affordability converging with the cost of increasingly complex and personalized medicines to make today’s economics unsustainable. Scott Howell and Ray Pressburger discuss what can be done to help solve these challenges across the industry.

Introducing our first deep dive into pharma's indispensable partner—the 3PL

Can technology really build trust in pharmaceutical supply chains?

A prescription for making the pharma supply chain more resilient, reliable and disruption-proof

The promise of advanced AI in transforming the value picture in drug development

Hurricane Ida reminds us of the importance of an effective supply chain

Gains in temperature-controlled logistics, accelerated by the pandemic, have reshaped the landscape for global pharma distribution

Taking stock of lessons learned during pandemic—and opportunities to grow stronger

Appreciating the human side of automation motives and approaches in the pharma supply chain

Catchphrase or not, the patient journey is seemingly more complex than ever these days—upping the ante for new strategies in specialty-care support

The Covid-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes

Drug abuse and suicide rates point to the need to address mental health

Ownership of supply chain data is becoming contentious

Higher quality service for both patients and manufacturers

IoT takes you from living in the past to shaping the future